18F-FDG PET/CT AS AN ASSESSMENT TOOL OF HEPATOCELLULAR CARCINOMA SECONDARY TO NON-ALCOHOLIC FATTY LIVER DISEASE DEVELOPMENT IN EXPERIMENTAL MODEL.
Caio de Souza LevyFernando Gomes de Barros CostaDaniele de Paula FariaJose Tadeu StefanoBruno CogliatiClaudia Pinto Marques Souza de OliveiraPublished in: Arquivos de gastroenterologia (2019)
18F-FDG PET/CT was able to evaluate the development of HCC in an experimental model of NAFLD non-invasively. From the standardization of PET/CT in this model, it is possible to use this tool in future studies to monitor, in vivo and non-invasively, the progression of HCC.